Director/PDMR Shareholding
Updated : 09:03
LEI: 213800EHT3TI1KPQQJ56
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
On 6 May 2020 Calum MacLean, Chief Executive Officer, Synthomer plc ("the Company"), exercised a nil cost long term incentive plan award over 17,316 ordinary shares granted in 2017 under the Company's 2011 Performance Share Plan. Mr MacLean has retained all such shares and will pay the cost of the resultant tax liability in cash in order to avoid the disposal of any shares.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Calum MacLean
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Chief Executive Officer | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Synthomer plc | |||
b)
| LEI
| 213800EHT3TI1KPQQJ56 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10p each | |||
Identification code | GB0009887422 | ||||
b)
| Nature of the transaction
| Exercise of long term incentive plan award granted in 2017 under the 2011 Performance Share Plan
| |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
Nil | 17,316 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 17,316 | ||||
- Price | Nil | ||||
e)
| Date of the transaction
| 6 May 2020 | |||
f)
| Place of the transaction
| Not applicable |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.